Dr Philippe Danjou
Scientific Advisor
Pharmaceuticals
Bionomics
Australia
Biography
Dr Danjou is a Clinical Pharmacologist from Paris University. He trained at the Pitié-Salpétriêre Hospital and received his Medical Degree in 1984 which he followed with a PhD in human biology in 1990. After doing Post-Doctoral studies in anxiety at the New York Psychiatric Institute, and a short university career in France, he spent 20 years in the Pharmaceutical Industry where he was involved in the early development of compounds that were successfully registered such as Zolpidem (Synthelabo), Zaleplon and Venlafaxine (Wyeth). As Head of Clinical Pharmacology at Sanofi, Dr Danjou gained experience in Clinical Psychiatry and Human Pharmacodynamics.
Research Interest
Research interest on Business Development
